-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AzR1MWA5Hc1P0wTFut1jFapZuxQWdlV59hcAao8UZRk2NjkODay7LGf9YaSw7N/n MqOe4Nrp+l7siS6O+xACLA== 0000950135-96-002521.txt : 19960607 0000950135-96-002521.hdr.sgml : 19960607 ACCESSION NUMBER: 0000950135-96-002521 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960331 FILED AS OF DATE: 19960606 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENETICS INSTITUTE INC CENTRAL INDEX KEY: 0000731336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042718435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 000-14587 FILM NUMBER: 96577525 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGE PK DR CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 6178761170 MAIL ADDRESS: STREET 1: 87 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 10-C 1 GENETIC INSTITUTE, INC. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-C REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ INTERDEALER QUOTATION SYSTEM FILED PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17 OR 15d-17 THEREUNDER GENETICS INSTITUTE, INC. - -------------------------------------------------------------------------------- (Exact name of issuer as specified in charter) 87 CambridgePark Dr., Cambridge, MA 02140 - -------------------------------------------------------------------------------- (Address of principal executive offices) Issuer's telephone number, including area code (617)876-1170 --------------------------------- I. CHANGE IN NUMBER OF SHARES OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding: 1. Title of security: Common Stock, $0.01 par value per share ------------------------------------------------------- 2. Number of shares outstanding before the change: 27,468,963 -------------------------- 3. Number of shares outstanding after the change: 29,531,619 --------------------------- 4. Effective date of change: May 31, 1996 ------------------------------------------------ 5. Method of change: Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.) Warrant and stock option exercises, issuances -------------------------------------------------------- under Employee Stock Purchase Plan. ------------------------------------------------------------------------- Give brief description of transaction: Issuance of stock as a result ---------------------------------- of (1) exercises of stock options under stock option plan, (2) exercise ------------------------------------------------------------------------- of warrants and (3) issuances under Employee Stock Purchase Plan. ------------------------------------------------------------------------- II. CHANGE IN NAME OF ISSUER 1. Name prior to change: N/A --------------------------------------------------- 2. Name after change: N/A ----------------------------------------------------- 3. Effective date of charter amendment changing name: N/A ---------------------- 4. Date of shareholder approval of change, if required: N/A -------------------- Date: June 6, 1996 /s/ Garen G. Bohlin ------------------------------------------------------------------- Garen G. Bohlin, Executive Vice President & Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----